Keap1-Nrf2 pathway: a key mechanism in the occurrence and development of cancer

被引:28
作者
Chen, Feilong [1 ]
Xiao, Mei [2 ]
Hu, Shaofan [3 ]
Wang, Meng [3 ]
机构
[1] Chengdu Sport Univ, Inst Sports Med & Hlth, Expert Ctr Sichuan Prov, Sports Med Key Lab Sichuan Prov, Chengdu, Peoples R China
[2] Chongqing Univ, Coll Bioengn, Chongqing, Peoples R China
[3] Third Mil Med Univ, Mil Med Univ 3, Dept Biochem & Mol Biol, Chongqing, Peoples R China
基金
中国博士后科学基金;
关键词
Keap1; Nrf2; cancer; structure; function; transcriptional regulation; prevention; clinical; TRANSCRIPTION FACTOR NRF2; CUL3-BASED E3 LIGASE; OXIDATIVE STRESS; SIGNALING PATHWAY; ANTIOXIDANT RESPONSE; PROTEASOMAL DEGRADATION; MOLECULAR-MECHANISMS; STRUCTURAL BASIS; LUNG-CANCER; ACTIVATION;
D O I
10.3389/fonc.2024.1381467
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The Keap1-Nrf2 signaling pathway is a major regulator of the cytoprotective response, participating in endogenous and exogenous stress caused by ROS (reactive oxygen species). Nrf2 is the core of this pathway. We summarized the literature on Keap1-Nrf2 signaling pathway and summarized the following three aspects: structure, function pathway, and cancer and clinical application status. This signaling pathway is similar to a double-edged sword: on the one hand, Nrf2 activity can protect cells from oxidative and electrophilic stress; on the other hand, increasing Nrf2 activity can enhance the survival and proliferation of cancer cells. Notably, oxidative stress is also considered a marker of cancer in humans. Keap1-Nrf2 signaling pathway, as a typical antioxidant stress pathway, is abnormal in a variety of human malignant tumor diseases (such as lung cancer, liver cancer, and thyroid cancer). In recent years, research on the Keap1-Nrf2 signaling pathway has become increasingly in-depth and detailed. Therefore, it is of great significance for cancer prevention and treatment to explore the molecular mechanism of the occurrence and development of this pathway.
引用
收藏
页数:12
相关论文
共 137 条
[11]   Structural Basis for Cul3 Protein Assembly with the BTB-Kelch Family of E3 Ubiquitin Ligases [J].
Canning, Peter ;
Cooper, Christopher D. O. ;
Krojer, Tobias ;
Murray, James W. ;
Pike, Ashley C. W. ;
Chaikuad, Apirat ;
Keates, Tracy ;
Thangaratnarajah, Chancievan ;
Hojzan, Viktorija ;
Marsden, Brian D. ;
Gileadi, Opher ;
Knapp, Stefan ;
von Delft, Frank ;
Bullock, Alex N. .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2013, 288 (11) :7803-7814
[12]   Nrf1 Is Endowed with a Dominant Tumor-Repressing Effect onto the Wnt/β-Catenin-Dependent and Wnt/β-Catenin-Independent Signaling Networks in the Human Liver Cancer [J].
Chen, Jiayu ;
Wang, Meng ;
Xiang, Yuancai ;
Ru, Xufang ;
Ren, Yonggang ;
Liu, Xiping ;
Qiu, Lu ;
Zhang, Yiguo .
OXIDATIVE MEDICINE AND CELLULAR LONGEVITY, 2020, 2020
[13]   Luteolin inhibits the Nrf2 signaling pathway and tumor growth in vivo [J].
Chian, Song ;
Thapa, Ruby ;
Chi, Zhexu ;
Wang, Xiu Jun ;
Tang, Xiuwen .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2014, 447 (04) :602-608
[14]   Nrf2-regulated PPARγ Expression Is Critical to Protection against Acute Lung Injury in Mice [J].
Cho, Hye-Youn ;
Gladwell, Wesley ;
Wang, Xuting ;
Chorley, Brian ;
Be, Douglas ;
Reddy, Sekhar P. ;
Kleeberger, Steven R. .
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2010, 182 (02) :170-182
[15]   Nrf2 is controlled by two distinct β-TrCP recognition motifs in its Neh6 domain, one of which can be modulated by GSK-3 activity [J].
Chowdhry, S. ;
Zhang, Y. ;
McMahon, M. ;
Sutherland, C. ;
Cuadrado, A. ;
Hayes, J. D. .
ONCOGENE, 2013, 32 (32) :3765-3781
[16]   KEAP1-NRF2 protein-protein interaction inhibitors: Design, pharmacological properties and therapeutic potential [J].
Crisman, Enrique ;
Duarte, Pablo ;
Dauden, Esteban ;
Cuadrado, Antonio ;
Rodriguez-Franco, Maria Isabel ;
Lopez, Manuela G. ;
Leon, Rafael .
MEDICINAL RESEARCH REVIEWS, 2023, 43 (01) :237-287
[18]   The Keap1-BTB protein is an adaptor that bridges Nrf2 to a Cul3-based E3 ligase: Oxidative stress sensing by a Cul3-Keap1 ligase [J].
Cullinan, SB ;
Gordan, JD ;
Jin, JO ;
Harper, JW ;
Diehl, JA .
MOLECULAR AND CELLULAR BIOLOGY, 2004, 24 (19) :8477-8486
[19]   Ensembl 2019 [J].
Cunningham, Fiona ;
Achuthan, Premanand ;
Akanni, Wasiu ;
Allen, James ;
Amode, M. Ridwan ;
Armean, Irina M. ;
Bennett, Ruth ;
Bhai, Jyothish ;
Billis, Konstantinos ;
Boddu, Sanjay ;
Cummins, Carla ;
Davidson, Claire ;
Dodiya, Kamalkumar Jayantilal ;
Gall, Astrid ;
Giron, Carlos Garcia ;
Gil, Laurent ;
Grego, Tiago ;
Haggerty, Leanne ;
Haskell, Erin ;
Hourlier, Thibaut ;
Izuogu, Osagie G. ;
Janacek, Sophie H. ;
Juettemann, Thomas ;
Kay, Mike ;
Laird, Matthew R. ;
Lavidas, Ilias ;
Liu, Zhicheng ;
Loveland, Jane E. ;
Marugan, Jose C. ;
Maurel, Thomas ;
McMahon, Aoife C. ;
Moore, Benjamin ;
Morales, Joannella ;
Mudge, Jonathan M. ;
Nuhn, Michael ;
Ogeh, Denye ;
Parker, Anne ;
Parton, Andrew ;
Patricio, Mateus ;
Salam, Ahamed Imran Abdul ;
Schmitt, Bianca M. ;
Schuilenburg, Helen ;
Sheppard, Dan ;
Sparrow, Helen ;
Stapleton, Eloise ;
Szuba, Marek ;
Taylor, Kieron ;
Threadgold, Glen ;
Thormann, Anja ;
Vullo, Alessandro .
NUCLEIC ACIDS RESEARCH, 2019, 47 (D1) :D745-D751
[20]   NRF2 and the Hallmarks of Cancer [J].
de la Vega, Montserrat Rojo ;
Chapman, Eli ;
Zhang, Donna D. .
CANCER CELL, 2018, 34 (01) :21-43